Citi analyst Atif Malik lowered the firm’s price target on Nova to $123 from $1303 and keeps a Buy rating on the shares post the September quarter results. The analyst views Nova as a beneficiary of rising 3D devices metrology capital intensity and expects the company’s sales to outperform the equipment markets over the next three years.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVMI:
- Nova Reports Results for Third Quarter of 2022
- AdaptHealth, HealthEquity, ViaSat added to ‘Endeavor List’ at BofA
- Nova price target lowered to $107 from $130 at BofA
Questions or Comments about the article? Write to editor@tipranks.com